The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE carries out new medical evacuation from Gaza Strip
IRENA Council meets in Abu Dhabi to drive global energy transition
H.H. Sheikh Mohammed unveils body to 'empower volunteering, promote goodness'
'Don't click on 50% discount deals': Dubai Opera warns of fake tickets scam
UAE President, European Council chief stress need to maintain Gaza ceasefire
H.H. Sheikh Ahmed hails national media as crucial pillar of development
Sheikha Bodour Al Qasimi appointed UNESCO Goodwill Ambassador
UAE unveils first Green Innovation District at Expo City
